Infusion fluids contain harmful glucose degradation products

PURPOSE: Glucose degradation products (GDPs) are precursors of advanced glycation end products (AGEs) that cause cellular damage and inflammation. We examined the content of GDPs in commercially available glucose-containing infusion fluids and investigated whether GDPs are found in patients’ blood....

Descripción completa

Detalles Bibliográficos
Autores principales: Bryland, Anna, Broman, Marcus, Erixon, Martin, Klarin, Bengt, Lindén, Torbjörn, Friberg, Hans, Wieslander, Anders, Kjellstrand, Per, Ronco, Claudio, Carlsson, Ola, Godaly, Gabriela
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882046/
https://www.ncbi.nlm.nih.gov/pubmed/20397009
http://dx.doi.org/10.1007/s00134-010-1873-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882046/
https://www.ncbi.nlm.nih.gov/pubmed/20397009
http://dx.doi.org/10.1007/s00134-010-1873-x

Ejemplares similares